Plant Comparison

Arnica vs Bay-leaf willowherb

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant AArnicaArnica montanaAsteraceaeFull monograph →
Plant BBay-leaf willowherbEpilobium parviflorumOnagraceaeFull monograph →

At a glance

Arnica and Bay-leaf willowherb: they share 6 indicated uses (arthritis / joint pain, cancer (anticancer research), infection (general), …); 4 pharmacological actions in common.

ArnicaBay-leaf willowherb
Constituents43
Pharmacological actions64
Indicated uses129
Safety notes42
Cited sources1815
Indicated uses
Only Arnica
Back painBruisingHeadacheMuscle sorenessPain (general)Swelling / fluid retention
Shared (6)
Arthritis / joint painCancer (anticancer research)Infection (general)Inflammation (general)Skin irritationWounds
Only Bay-leaf willowherb
Prostate supportUrinary supportUrinary tract infection (UTI)
Pharmacological actions
Only Arnica
Analgesic (pain relief)Vulnerary (wound healing)
Shared (4)
Anti-inflammatoryAnticancer (preclinical)AntimicrobialAntioxidant
Only Bay-leaf willowherb
none

Evidence face-off — shared uses

ConditionArnicaBay-leaf willowherbVerdict
Arthritis / joint pain7/101/10Stronger for Arnica
Cancer (anticancer research)2/102/10Comparable evidence
Infection (general)1/101/10Comparable evidence
Inflammation (general)7/101/10Stronger for Arnica
Skin irritation7/101/10Stronger for Arnica
Wounds1/101/10Comparable evidence

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Sesquiterpene lactones (helenalin, dihydrohelenalin)[4]

The main anti-inflammatory principles; also responsible for the plant's toxicity and contact-allergy potential.

Sesquiterpene lactonesSesquiterpenes
Flavonoids[4]

Antioxidant and anti-inflammatory constituents.

Flavonoids
Essential oil, phenolic acids and coumarins[4]

Aromatic and supporting constituents of the flower.

Phenolic acidsEssential (volatile) oilCoumarins
Pyrrolizidine alkaloids (trace)[4]

Present in small amounts; relevant to the caution against internal use.

Alkaloids
Macrocyclic ellagitannins (notably oenothein B)[4, 5, 6, 7, 8, 13]

Characteristic Epilobium polyphenols underlying the anti-inflammatory and prostate activity; a genus review identifies oenothein B as the dominant constituent and likely driver of the antimicrobial, anti-inflammatory, anti-proliferative and antioxidant effects.

TanninsPhenolic compounds
Flavonoids (myricetin and quercetin glycosides)[11, 13]

Antioxidant constituents.

FlavonoidsGlycosidesQuercetin
Plant sterols (beta-sitosterol)[13]

Sterols associated with benign prostatic hyperplasia support.

Phytosterols

Pharmacological Actions

Analgesic (pain relief)[4, 5, 15]

Topical analgesic for muscle soreness and pain

Anti-inflammatory[2, 4, 5, 6, 7, 8, 12, 15]

Topical anti-inflammatory for bruising, swelling and sprains

Anticancer (preclinical)[11, 16, 17]

Helenalin, the sesquiterpene lactone of Arnica montana, shows anticancer activity against multiple tumour types in vitro and in vivo, largely by covalently inhibiting NF-kappaB p65 and inducing apoptosis (preclinical).

Antimicrobial[4, 11]

Antimicrobial and antioxidant (in vitro)

Antioxidant[4, 11, 13]

Antimicrobial and antioxidant (in vitro)

Vulnerary (wound healing)[4, 9, 10]

Antiecchymotic / vulnerary (helps disperse bruises)

Anti-inflammatory[1, 3, 4, 6, 10, 13]

Anti-inflammatory (inhibits COX-1 and COX-2 prostaglandin synthesis)

Anticancer (preclinical)[3]
Antimicrobial[13]

Antibacterial, including against Escherichia coli (urinary support)

Antioxidant[1, 6, 9, 10, 11, 13]

Antioxidant (hydroxyl-radical scavenging)

Traditional & Indicated Uses

Arthritis / joint pain[4, 15]Good · 7/10

inferred from anti-inflammatory action

Evidence: 7
Label: Arthritis / joint pain
Back pain[4, 15]Good · 7/10

inferred from analgesic action

Evidence: 7
Label: Back pain
Bruising[4, 15]Good · 7/10

Antiecchymotic / vulnerary (helps disperse bruises); Topical anti-inflammatory for bruising, swelling and sprains

Evidence: 7
Label: Bruising
Cancer (anticancer research)[11, 16, 17]Traditional · 2/10

Arnica montana and its constituent helenalin exert anticancer activity against several tumour types in vitro and in vivo, inhibiting NF-kappaB (p65) signalling, inducing apoptosis and synergizing with other anticancer agents (preclinical).

Evidence: 2
Label: Cancer (anticancer research)
Headache[4, 15]Good · 7/10

inferred from analgesic action

Evidence: 7
Label: Headache
Infection (general)[4]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[4, 15]Good · 7/10

inferred from anti-inflammatory action

Evidence: 7
Label: Inflammation (general)
Muscle soreness[4, 15]Good · 7/10

Topical analgesic for muscle soreness and pain

Evidence: 7
Label: Muscle soreness
Pain (general)[4, 15]Good · 7/10

Topical analgesic for muscle soreness and pain

Evidence: 7
Label: Pain (general)
Skin irritation[4, 15]Good · 7/10

inferred from anti-inflammatory action

Evidence: 7
Label: Skin irritation
Swelling / fluid retention[4, 15]Good · 7/10

Topical anti-inflammatory for bruising, swelling and sprains

Evidence: 7
Label: Swelling / fluid retention
Wounds[4]Traditional · 1/10

inferred from vulnerary action

Evidence: 1
Label: Wounds
Arthritis / joint pain[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cancer (anticancer research)[3]Traditional · 2/10

inferred from anticancer action

Evidence: 2
Label: Cancer (anticancer research)
Infection (general)[13]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Prostate support[4, 13, 15]Moderate · 5/10

Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive

Evidence: 5
Label: Prostate support
Skin irritation[13]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Urinary support[4, 13, 15]Moderate · 5/10

Antibacterial, including against Escherichia coli (urinary support); Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive

Evidence: 5
Label: Urinary support
Urinary tract infection (UTI)[4, 13, 15]Moderate · 5/10

Supports lower urinary tract symptoms of benign prostatic hyperplasia (prostate support) - a genus Epilobium review notes traditional BPH use attributed mainly to oenothein B, though clinical evidence is not yet conclusive

Evidence: 5
Label: Urinary tract infection (UTI)
Wounds[13]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds

Safety, Cautions & Contraindications

Safety note[4, 18]Info

EXTERNAL USE ONLY on unbroken skin. Arnica is toxic if swallowed and can cause stomach pain, vomiting, diarrhoea, breathing difficulty, irregular heartbeat and, in serious cases, cardiac arrest; the only safe oral form is the highly diluted homeopathic preparation.

Safety note[18]Caution

Do not apply to broken or damaged skin, open wounds, eyes or mucous membranes.

Safety note[4]Info

As a member of the daisy family (Asteraceae) it can cause allergic contact dermatitis; prolonged topical use can also irritate the skin.

Safety note[15, 18]Caution

Avoid medicinal use during pregnancy and breastfeeding.

Safety note[15]Info

Lower urinary tract / prostate symptoms must be medically assessed first to exclude prostate cancer; willowherb is a supportive measure, not a substitute for diagnosis and treatment.

Safety note[15]Info

Well tolerated over three months in clinical use; longer-term safety data are limited.

External Ids

Gbif: 5405976
Wikidata: Q207848
Gbif: 3189157
Wikidata: Q159094

Botanical Description

Aromatic mountain perennial herb with a basal rosette of oval, hairy leaves and one or two pairs of smaller opposite leaves on an erect, softly hairy flowering stem. Each stem bears one or a few large, bright golden-yellow, daisy-like flower heads with narrow, slightly twisted ray florets.[4]

Height: 20-60 cm
Habit: Erect, aromatic mountain perennial herb
Leaves: Basal rosette of oval, hairy leaves; one or two pairs of smaller opposite stem leaves
Flowers: Large, bright golden-yellow, daisy-like flower heads with narrow, slightly twisted ray florets
Stem: Erect, softly hairy, sparsely leaved flowering stem
Root: Short, blackish rhizome with fibrous roots
Fruit: Small, hairy achene with a pappus
Flowering Period: June-August

Slender, softly hairy perennial herb with narrow, lance-shaped leaves and small, four-petalled, pale pink to lilac flowers with a notched tip, borne singly in the upper leaf axils. After flowering, long, narrow seed pods split to release cottony-tufted seeds, typical of the willowherb genus.[13]

Height: 20-60 cm
Habit: Slender, softly hairy, erect perennial herb
Leaves: Narrow, lance-shaped, softly hairy
Flowers: Small, four-petalled, pale pink to lilac, notched, borne singly in upper leaf axils
Stem: Slender, softly hairy, erect
Root: Fibrous root with short rhizome
Fruit: Long, narrow seed pod releasing cottony-tufted seeds
Flowering Period: June-September

Habitat

Grows in acidic, nutrient-poor mountain meadows, pastures and open woodland, typically at moderate to high elevations across central and northern Europe; increasingly scarce in the wild due to habitat loss and overharvesting.[4]

Grows in damp meadows, ditches, streamsides and waste ground on moist soils; native to Europe and temperate Asia.[13]

Harvesting

The flower heads are picked by hand as they open, in mid- to late summer, and dried quickly in a warm, shaded, airy place; wild populations are protected in many regions, so cultivated or sustainably wildcrafted material is preferred.[4]

Parts: Flower head (topical preparations)
Season: Mid- to late summer, as flowers open

The flowering aerial parts are cut in summer while in flower, and dried in a warm, shaded, airy place.[13]

Parts: Aerial parts (herb)
Season: Summer flowering period

Traditional Uses

Arnica flower has a long central European folk reputation, reflected in the name 'leopard's bane' and 'mountain tobacco', as a topical remedy for bruising, sprains, muscle soreness and swelling after minor injury, applied only to unbroken skin. Internal use of the whole herb has always been considered dangerous and is confined to highly diluted homeopathic preparations.[4]

Small-flowered willowherb, along with related Epilobium species, has a Central European folk tradition as a supportive remedy for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) and prostatitis, and as an antimicrobial and anti-inflammatory herb for minor infections; the traditional prostate-support use is attributed mainly to its oenothein B content, though robust clinical evidence remains limited.[13]

Preparations

Topical cream/gel/ointment[4]

Standardised flower extract formulated into a cream, gel or ointment for external application to bruises, sprains and muscle soreness on unbroken skin.

Diluted tincture (topical)[4]

Alcoholic tincture of the dried flower heads, diluted before topical application as a compress; never taken internally in this form.

Infusion[13]

Dried flowering herb infused in hot water as a traditional urinary and prostate-support tea.

Dosage

Topical cream/gel[14]

The EU herbal monograph gives cutaneous use only, in adolescents, adults and elderly - a semi-solid preparation containing 20-25% tincture applied as a thin layer 2-3 times daily, a 50% liquid-extract preparation 2-4 times daily, or 2.5 mL of a liquid preparation as an impregnated dressing 3-4 times daily. Apply to unbroken skin only. If symptoms persist after 3 to 4 days a healthcare practitioner should be consulted. Not recommended under 12 years. Never taken by mouth except as a highly diluted homeopathic preparation. Educational reference only, not a prescription.

Infusion[14]

The EU herbal monograph gives 1.5-2.0 g of the comminuted herb in 250 mL of boiling water as an infusion, twice daily, in adults and elderly; long-term use is possible. Lower urinary tract or prostate symptoms should always be medically assessed first, and the monograph directs that a doctor be consulted if fever, spasms, blood in the urine, painful urination or urinary retention occur. Educational reference only, not a prescription.

References

REF-0725, REF-0726, REF-0727, REF-0398, REF-2098, REF-2099, REF-2100, REF-2101, REF-2102, REF-2103, REF-2104, REF-2105, REF-2106
REF-0803, REF-0804, REF-0805, REF-0618, REF-2297, REF-2298, REF-2299, REF-2300, REF-2301, REF-2302, REF-2303, REF-2304

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Toma, C.C., Marrelli, M., Puticiu, M., Conforti, F. and Statti, G (2024) 'Effects of Arnica montana Phytotherapeutic and Homeopathic Formulations on Traumatic Injuries and Inflammatory Conditions: A Systematic Review', Plants (Basel), 13(21), pp. 3112. doi:10.3390/plants13213112 Meta-analysis / review
    https://doi.org/10.3390/plants13213112
  2. Schmidt, T.J (2023) 'Arnica montana L.: Doesn't Origin Matter?', Plants (Basel), 12(20), pp. 3532. doi:10.3390/plants12203532 Traditional / reference
    https://doi.org/10.3390/plants12203532
  3. Dragos, D., Gilca, M., Gaman, L., Vlad, A., Iosif, L. et al (2017) 'Phytomedicine in Joint Disorders', Nutrients, 9(1), pp. 70. doi:10.3390/nu9010070 Traditional / reference
    https://doi.org/10.3390/nu9010070
  4. Kriplani, P., Guarve, K. and Baghael, U.S (2017) 'Arnica montana L. - a plant of healing: review', Journal of Pharmacy and Pharmacology, pp. 12724. doi:10.1111/jphp.12724 Traditional / reference
    https://doi.org/10.1111/jphp.12724
  5. Iannitti, T., Morales-Medina, J.C., Bellavite, P., Rottigni, V. and Palmieri, B (2016) 'Effectiveness and safety of Arnica montana in post-surgical setting, pain and inflammation', American Journal of Therapeutics, 23(1), pp. e184-e197. doi:10.1097/MJT.0000000000000036 Meta-analysis / review
    https://doi.org/10.1097/MJT.0000000000000036
  6. Verre, J., Boisson, M., Paumier, A., Tribolo, S. and Boujedaini, N (2023) 'Anti-inflammatory effects of Arnica montana (mother tincture and homeopathic dilutions) in various cell models', Journal of Ethnopharmacology, 318(Pt B), pp. 117064. doi:10.1016/j.jep.2023.117064 Preclinical
    https://doi.org/10.1016/j.jep.2023.117064
  7. Rohrl, J., Pique-Borras, M., Jaklin, M., Werner, M., Werz, O., Josef, H., Holz, H., Ammendola, A. and Kunstle, G (2023) 'Anti-inflammatory activities of Arnica montana planta tota versus flower extracts: analytical, in vitro and in vivo mouse paw oedema model studies', Plants, 12(6), pp. 1348. doi:10.3390/plants12061348 Preclinical
    https://doi.org/10.3390/plants12061348
  8. da Silva Prade, J., Balsamo, E.C., Machado, F.R., Poetini, M.R., Bortolotto, V.C., Araujo, S.M., Londero, L., Boeira, S.P., Sehn, C.P., de Gomes, M.G., Prigol, M. and Cattelan Souza, L (2020) 'Anti-inflammatory effect of Arnica montana in a UVB radiation-induced skin-burn model in mice', Cutaneous and Ocular Toxicology, 39(2), pp. 126-133. doi:10.1080/15569527.2020.1743998 Preclinical
    https://doi.org/10.1080/15569527.2020.1743998
  9. Zacarias, C.A., de Mendonca Florenziano, R.F., de Andrade, T.A.M., de Aro, A.A., do Amaral, M.E.C., Dos Santos, G.M.T. and Esquisatto, M.A.M (2023) 'Arnica montana L. associated with microcurrent accelerates the dermis reorganisation of skin lesions', International Journal of Experimental Pathology, 104(2), pp. 81-95. doi:10.1111/iep.12469 Preclinical
    https://doi.org/10.1111/iep.12469
  10. Chaiet, S.R. and Marcus, B.C (2016) 'Perioperative Arnica montana for reduction of ecchymosis in rhinoplasty surgery', Annals of Plastic Surgery, 76(5), pp. 477-482. doi:10.1097/SAP.0000000000000312 Randomized trial
    https://doi.org/10.1097/SAP.0000000000000312
  11. Zitek, T., Postruznik, V., Knez, Z., Golle, A., Daris, B. and Knez Marevci, M (2022) 'Arnica montana L. supercritical extraction optimization for antibiotic and anticancer activity', Frontiers in Bioengineering and Biotechnology, 10, pp. 897185. doi:10.3389/fbioe.2022.897185 Preclinical
    https://doi.org/10.3389/fbioe.2022.897185
  12. Sutovska, M., Capek, P., Kocmalova, M., Pawlaczyk, I., Zaczynska, E., Czarny, A., Uhliarikova, I., Gancarz, R. and Franova, S (2014) 'Characterization and pharmacodynamic properties of Arnica montana complex', International Journal of Biological Macromolecules, 69, pp. 214-221. doi:10.1016/j.ijbiomac.2014.05.051 Preclinical
    https://doi.org/10.1016/j.ijbiomac.2014.05.051
  13. Merfort, I. and Wendisch, D (1987) 'Flavonoid glycosides from Arnica montana and Arnica chamissonis', Planta Medica, 53(5), pp. 434-437. doi:10.1055/s-2006-962766 Preclinical
    https://doi.org/10.1055/s-2006-962766
  14. European Medicines Agency (HMPC) (2012) 'Community herbal monograph on Arnica montana L., flos'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arnica-montana-l-flos_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-arnica-montana-l-flos_en.pdf
  15. Gaertner, K., Baumgartner, S. and Walach, H (2021) 'Is Homeopathic Arnica Effective for Postoperative Recovery? A Meta-analysis of Placebo-Controlled and Active Comparator Trials', Frontiers in Surgery. doi:10.3389/fsurg.2021.680930 Meta-analysis / review
    https://doi.org/10.3389/fsurg.2021.680930
  16. Kriplani, P. and Guarve, K (2020) 'Recent Patents on Anti-Cancer Potential of Helenalin', Recent Patents on Anti-Cancer Drug Discovery, 15(2), pp. 132-142. doi:10.2174/1574892815666200702142601 Preclinical
    https://doi.org/10.2174/1574892815666200702142601
  17. Drogosz, J. and Janecka, A (2019) 'Helenalin - A Sesquiterpene Lactone with Multidirectional Activity', Current Drug Targets, 20(4), pp. 444-452. doi:10.2174/1389450119666181012125230 Preclinical
    https://doi.org/10.2174/1389450119666181012125230
  18. National Capital Poison Center (Poison Control) (n.d.) 'Caution when using Arnica products'. Available at: https://www.poison.org/articles/caution-when-using-arnica-products-193 Traditional / reference
    https://www.poison.org/articles/caution-when-using-arnica-products-193
  1. Vitalone, A. and Allkanjari, O (2018) 'Epilobium spp: Pharmacology and Phytochemistry', Phytotherapy Research, 32(7), pp. 1229-1240. doi:10.1002/ptr.6072 Traditional / reference
    https://doi.org/10.1002/ptr.6072
  2. Cicero, A.F.G., Allkanjari, O., Busetto, G.M., Cai, T. et al (2019) 'Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer', Archivio Italiano di Urologia e Andrologia, 91(3), pp. 139-152. doi:10.4081/aiua.2019.3.139 Traditional / reference
    https://doi.org/10.4081/aiua.2019.3.139
  3. Vlase, A.M., Toiu, A., Gligor, O., Muntean, D. et al (2024) 'Investigation of Epilobium hirsutum L. Optimized Extract's Anti-Inflammatory and Antitumor Potential', Plants (Basel), 13(2), pp. 198. doi:10.3390/plants13020198 Preclinical
    https://doi.org/10.3390/plants13020198
  4. Granica, S., Piwowarski, J.P., Czerwinska, M.E. and Kiss, A.K (2014) 'Phytochemistry, pharmacology and traditional uses of different Epilobium species (Onagraceae): a review', Journal of Ethnopharmacology, pp. 316--346. doi:10.1016/j.jep.2014.08.036 Traditional / reference
    https://doi.org/10.1016/j.jep.2014.08.036
  5. Ramstead, A.G., Schepetkin, I.A., Quinn, M.T. and Jutila, M.A (2012) 'Oenothein B, a cyclic dimeric ellagitannin isolated from Epilobium angustifolium, enhances IFN-gamma production by lymphocytes', PLoS One, 7(11), pp. e50546. doi:10.1371/journal.pone.0050546 Preclinical
    https://doi.org/10.1371/journal.pone.0050546
  6. Kiss, A.K., Bazylko, A., Filipek, A., Granica, S., Jaszewska, E., Kiarszys, U., Kosmider, A. and Piwowarski, J (2011) 'Oenothein B's contribution to the anti-inflammatory and antioxidant activity of Epilobium sp', Phytomedicine, 18(7), pp. 557-560. doi:10.1016/j.phymed.2010.10.016 Preclinical
    https://doi.org/10.1016/j.phymed.2010.10.016
  7. Schepetkin, I.A., Kirpotina, L.N., Jakiw, L., Khlebnikov, A.I., Blaskovich, C.L., Jutila, M.A. and Quinn, M.T (2009) 'Immunomodulatory activity of oenothein B isolated from Epilobium angustifolium', Journal of Immunology, 183(10), pp. 6754-6766. doi:10.4049/jimmunol.0901827 Preclinical
    https://doi.org/10.4049/jimmunol.0901827
  8. Ducrey, B., Marston, A., Gohring, S., Hartmann, R.W. and Hostettmann, K (1997) 'Inhibition of 5-alpha-reductase and aromatase by the ellagitannins oenothein A and oenothein B from Epilobium species', Planta Medica, 63(2), pp. 111-114. doi:10.1055/s-2006-957624 Preclinical
    https://doi.org/10.1055/s-2006-957624
  9. Schepetkin, I.A., Ramstead, A.G., Kirpotina, L.N., Voyich, J.M., Jutila, M.A. and Quinn, M.T (2016) 'Therapeutic potential of polyphenols from Epilobium angustifolium (fireweed)', Phytotherapy Research, 30(8), pp. 1287-1297. doi:10.1002/ptr.5648 Meta-analysis / review
    https://doi.org/10.1002/ptr.5648
  10. Merighi, S., Travagli, A., Tedeschi, P., Marchetti, N. and Gessi, S (2021) 'Antioxidant and anti-inflammatory effects of Epilobium parviflorum, Melilotus officinalis and Cardiospermum halicacabum plant extracts in macrophage and microglial cells', Cells, 10(10), pp. 2691. doi:10.3390/cells10102691 Preclinical
    https://doi.org/10.3390/cells10102691
  11. Hevesi Toth, B., Blazics, B. and Kery, A (2009) 'Polyphenol composition and antioxidant capacity of Epilobium species', Journal of Pharmaceutical and Biomedical Analysis, 49(1), pp. 26-31. doi:10.1016/j.jpba.2008.09.047 Preclinical
    https://doi.org/10.1016/j.jpba.2008.09.047
  12. Vitalone, A., McColl, J., Thome, D., Costa, L.G. and Tita, B (2003) 'Characterization of the effect of Epilobium extracts on human cell proliferation', Pharmacology, 69(2), pp. 79-87. doi:10.1159/000072360 Preclinical
    https://doi.org/10.1159/000072360
  13. Steenkamp, V., Gouws, M.C., Gulumian, M., Elgorashi, E.E. and van Staden, J (2005) 'Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis', Journal of Ethnopharmacology, pp. 2005. doi:10.1016/j.jep.2005.07.007 Traditional / reference
    https://doi.org/10.1016/j.jep.2005.07.007
  14. European Medicines Agency (HMPC) (2015) 'European Union herbal monograph on Epilobium angustifolium L. and/or Epilobium parviflorum Schreb., herba'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-epilobium-angustifolium-l-andor-epilobium-parviflorum-schreb-herba_en.pdf Traditional / reference
    https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-epilobium-angustifolium-l-andor-epilobium-parviflorum-schreb-herba_en.pdf
  15. Coulson, S., Rao, A., Beck, S.L., Steels, E., Gramotnev, H. and Vitetta, L (2013) 'A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation (containing Epilobium parviflorum) for the management of symptoms of benign prostatic hypertrophy', Complementary Therapies in Medicine. doi:10.1016/j.ctim.2013.01.007 Randomized trial
    https://doi.org/10.1016/j.ctim.2013.01.007

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.